Eurofarma Innovation and Growth Strategy
27
22
Brazilian Pharma
Total Market (Retail + Non-Retail)
Market- MAT
(R$ billion)
+11,5%
+29,0%
119
CAGR +16%
+10,6%
+12,6%
149
132
58
107
52
52
46
83
41
26
57
40
91
73
80
67
2017
2018
2019
Non Retail
Retail
2020
2021
1- Source: IBGE and IQVIA Mar/2022 | Retail - Reais PPP / Non Retail - Reais PP, excluding Covid-19 vaccines (R$163.4 bi considering vaccines).
eurofarma
☐
Brazil
According to IQVIA, the Brazilian market (retail + non-retail) is
expected to grow 9-12% per year between 2022 and 2026
Population aging and lifestyle habits drive demand for medicines
According to IBGE, ~10.7% of the Brazilian population was
60 years old or older in 2010. It increased to 14.3% in 2020
and it is estimated that, the population over 60 years old will
represent 32.2% in 2060
■ Gradual recovery in income levels due to slow economic recovery
Adoption of new technologies in smaller portions of the populationView entire presentation